FDA 483 - Pharmaceutics International Inc - March 18, 2016
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Pharmaceutics International Inc. in Hunt Valley, MD, a drug manufacturer, revealed significant deficiencies across multiple systems. Repeated observations included inadequate environmental controls and HVAC monitoring, insufficient cleaning validation and procedures, and critical failures in data integrity and quality control unit oversight. The firm also failed to thoroughly investigate discrepancies and maintain proper production documentation, indicating systemic issues in GMP compliance.
ID · 073299e1-26d0-4892-a7f1-668a441df51b